Françoise Garrouste

1.1k total citations
36 papers, 991 citations indexed

About

Françoise Garrouste is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Françoise Garrouste has authored 36 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 18 papers in Endocrinology, Diabetes and Metabolism and 16 papers in Cancer Research. Recurrent topics in Françoise Garrouste's work include Growth Hormone and Insulin-like Growth Factors (18 papers), Cancer, Hypoxia, and Metabolism (13 papers) and Metabolism, Diabetes, and Cancer (8 papers). Françoise Garrouste is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (18 papers), Cancer, Hypoxia, and Metabolism (13 papers) and Metabolism, Diabetes, and Cancer (8 papers). Françoise Garrouste collaborates with scholars based in France, Belgium and Japan. Françoise Garrouste's co-authors include M Remacle-Bonnet, Gilbert Pommier, Jacques Marvaldi, G. Pommier, Frederic André, Jean‐Michel Culouscou, B. Sastre, Scott Heller, Maxime Lehmann and Anne‐Marie Benoliel and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Clinical Endocrinology & Metabolism and The FASEB Journal.

In The Last Decade

Françoise Garrouste

35 papers receiving 964 citations

Peers

Françoise Garrouste
Iván Plaza-Menacho United Kingdom
Cuiqi Zhou United States
Angela Russo United States
Marco Arndt Germany
C L Hsieh United States
Françoise Garrouste
Citations per year, relative to Françoise Garrouste Françoise Garrouste (= 1×) peers Ploutarchos Anezinis

Countries citing papers authored by Françoise Garrouste

Since Specialization
Citations

This map shows the geographic impact of Françoise Garrouste's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Françoise Garrouste with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Françoise Garrouste more than expected).

Fields of papers citing papers by Françoise Garrouste

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Françoise Garrouste. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Françoise Garrouste. The network helps show where Françoise Garrouste may publish in the future.

Co-authorship network of co-authors of Françoise Garrouste

This figure shows the co-authorship network connecting the top 25 collaborators of Françoise Garrouste. A scholar is included among the top collaborators of Françoise Garrouste based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Françoise Garrouste. Françoise Garrouste is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Villard, Claude, Ludovic Leloup, Françoise Garrouste, et al.. (2023). Overexpression of a Novel Noxo1 Mutant Increases Ros Production and Noxo1 Relocalisation. International Journal of Molecular Sciences. 24(5). 4663–4663.
2.
Pagano, Alessandra, Gilles Breuzard, Aurélie Tchoghandjian, et al.. (2021). Tau Regulates Glioblastoma Progression, 3D Cell Organization, Growth and Migration via the PI3K-AKT Axis. Cancers. 13(22). 5818–5818. 15 indexed citations
3.
Pagano, Alessandra, Nicolas Andreotti, Françoise Garrouste, et al.. (2016). Peptide screen identifies a new NADPH oxidase inhibitor: impact on cell migration and invasion. European Journal of Pharmacology. 794. 162–172. 9 indexed citations
4.
Faure, Emilie, Françoise Garrouste, Sylvie Monferran, et al.. (2012). P2Y2 receptor inhibits EGF-induced MAPK pathway to stabilise keratinocyte hemidesmosomes.. Journal of Cell Science. 125(Pt 18). 4264–77. 11 indexed citations
5.
Taboubi, Salma, Françoise Garrouste, Gilbert Pommier, et al.. (2010). Gq-coupled Purinergic Receptors Inhibit Insulin-like Growth Factor-I/Phosphoinositide 3-Kinase Pathway-dependent Keratinocyte Migration. Molecular Biology of the Cell. 21(6). 946–955. 22 indexed citations
6.
Canonici, Alexandra, Wim F. A. Steelant, Véronique Rigot, et al.. (2007). Insulin‐like growth factor‐I receptor, E‐cadherin and αv integrin form a dynamic complex under the control of α‐catenin. International Journal of Cancer. 122(3). 572–582. 69 indexed citations
7.
Baillat, Gilbert, Françoise Garrouste, M Remacle-Bonnet, Jacques Marvaldi, & Gilbert Pommier. (2005). Bcl-xL/Bax ratio is altered by IFNγ in TNFα- but not in TRAIL-induced apoptosis in colon cancer cell line. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1745(1). 101–110. 10 indexed citations
8.
Baciuchka, Marjorie, M Remacle-Bonnet, Françoise Garrouste, et al.. (1998). Insulin-like growth factor (IGF)–binding protein-3 (IGFBP-3) proteolysis in patients with colorectal cancer: possible association with the metastatic potential of the tumor. International Journal of Cancer. 79(5). 460–467. 26 indexed citations
9.
Lehmann, Maxime, Frederic André, M Remacle-Bonnet, et al.. (1998). Deficient Processing and Activity of Type I Insulin-Like Growth Factor Receptor in the Furin-Deficient LoVo-C5 Cells*. Endocrinology. 139(9). 3763–3771. 41 indexed citations
10.
Baciuchka, Marjorie, M Remacle-Bonnet, Françoise Garrouste, et al.. (1998). Insulin‐like growth factor (IGF)–binding protein‐3 (IGFBP‐3) proteolysis in patients with colorectal cancer: possible association with the metastatic potential of the tumor. International Journal of Cancer. 79(5). 460–467. 6 indexed citations
12.
Garrouste, Françoise, M Remacle-Bonnet, Maxime Lehmann, Jacques Marvaldi, & Gilbert Pommier. (1997). Up-Regulation of Insulin/Insulin-Like Growth Factor-I Hybrid Receptors during Differentiation of HT29-D4 Human Colonic Carcinoma Cells1. Endocrinology. 138(5). 2021–2032. 24 indexed citations
13.
Remacle-Bonnet, M, et al.. (1996). Serum Factors Inhibit Melanoma Cell Surface Expression of Type I and Type II IGF Receptors. Journal of Receptors and Signal Transduction. 16(1-2). 115–134. 2 indexed citations
16.
Lehmann, Maxime, M Remacle-Bonnet, Françoise Garrouste, et al.. (1994). Surface Distribution of the EGF Receptor During Differentiation of the Human Colon Carcinoma Cell Line HT29-D4. Journal of Receptor Research. 14(5). 319–333. 5 indexed citations
18.
Culouscou, Jean‐Michel, M Remacle-Bonnet, Françoise Garrouste, et al.. (1990). Production of insulin‐like growth factor II (IGF‐II) and different forms of IGF‐binding proteins by HT‐29 human colon carcinoma cell line. Journal of Cellular Physiology. 143(3). 405–415. 41 indexed citations
19.
Culouscou, Jean‐Michel, et al.. (1988). Autocrine secretion of a colorectum‐derived growth factor by HT‐29 human colon carcinoma cell line. International Journal of Cancer. 42(6). 895–901. 21 indexed citations
20.
Culouscou, Jean‐Michel, et al.. (1987). Simultaneous production of IGF‐I and EGF competing growth factors by HT‐29 human colon cancer line. International Journal of Cancer. 40(5). 646–652. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026